A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe.

Altman, George; Ahuja, Janvi; Monrad, Joshua Teperowski; Dhaliwal, Gurpreet; Rogers-Smith, Charlie; Leech, Gavin; Snodin, Benedict; Sandbrink, Jonas B; Finnveden, Lukas; Norman, Alexander John; Oehm, Sebastian B; Sandkühler, Julia Fabienne; Kulveit, Jan; Flaxman, Seth; Gal, Yarin; Mishra, Swapnil; Bhatt, Samir; Sharma, Mrinank; Mindermann, Sören; Brauner, Jan Markus

View / Open Files

Published version (PDF, 1Mb)

Authors

Altman, George

Ahuja, Janvi

Monrad, Joshua Teperowski

Dhaliwal, Gurpreet

Rogers-Smith, Charlie

Leech, Gavin

Snodin, Benedict

Publication Date

2022-04-01

Journal Title

Sci Data

ISSN

2052-4463

Publisher

Springer Science and Business Media LLC

Volume

Issue

Language

eng

Type

Article

This Version

VoR

Metadata

Show full item record

Citation

Altman, G., Ahuja, J., Monrad, J. T., Dhaliwal, G., Rogers-Smith, C., Leech, G., Snodin, B., et al. (2022). A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe.. Sci Data, 9 (1) https://doi.org/10.1038/s41597-022-01175-y

Abstract

During the second half of 2020, many European governments responded to the resurging transmission of SARS-CoV-2 with wide-ranging non-pharmaceutical interventions (NPIs). These efforts were often highly targeted at the regional level and included fine-grained NPIs. This paper describes a new dataset designed for the accurate recording of NPIs in Europe's second wave to allow precise modelling of NPI effectiveness. The dataset includes interventions from 114 regions in 7 European countries during the period from the 1st August 2020 to the 9th January 2021. The paper includes NPI definitions tailored to the second wave following an exploratory data collection. Each entry has been extensively validated by semi-independent double entry, comparison with existing datasets, and, when necessary, discussion with local epidemiologists. The dataset has considerable potential for use in disentangling the effectiveness of NPIs and comparing the impact of interventions across different phases of the pandemic.

Keywords

Humans, Europe, COVID-19, SARS-CoV-2, Psychosocial Intervention, Mass Gatherings

Sponsorship

Novo Nordisk (NNF20OC0059309)

RCUK | Engineering and Physical Sciences Research Council (EPSRC) (EP/S024050/1, EP/V002910/1)

Academy of Medical Royal Colleges (AoMRC) (MR/R015600/1)

Imperial College Healthcare NHS Trust (RDA02)

Academy of Medical Sciences (SBF004/1080)

Biotechnology and Biological Sciences Research Council (BB/T008784/1)

Identifiers

35365668, PMC8975844

External DOI: https://doi.org/10.1038/s41597-022-01175-y

This record's URL: https://www.repository.cam.ac.uk/handle/1810/336838

Rights

Attribution 4.0 International

Licence URL: https://creativecommons.org/licenses/by/4.0/

Statistics

Total file downloads (since January 2020). For more information on metrics see the IRUS guide.

Except where otherwise noted, this item's licence is described as Attribution 4.0 International